B2M and amyloidosis: In a clinical trial comparing medium-cutoff membrane dialysis with traditional low-flux hemodialysis, it was found that medium-cutoff membrane dialysis could achieve a higher clearance rate for B2M, which is beneficial for preventing dialysis-related amyloidosis caused by the accumulation of B2M.